Diagnostics & Healthcare News
Hologic to Makes Second Major Acquisition of 2021, Acquires Biotheranostics for $230M
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject...